1ST Biotherapeutics, Inc.   Report issue

For profit Phase 1
Founded: Seongnam Korea, Republic of (2016)

Organization Overview

First Clinical Trial
2019
NCT04165837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

1ST Biotherapeutics, Inc.